Ten Things to Watch for 2025 ACA Open Enrollment
This blog post details ten things to know about the 2025 open enrollment period.
Read More
Understanding healthcare claim denials: reasons & solutions
Experian Health’s State of Claims 2024 report reveals a worrying trend in healthcare claim denials, with nearly three-quarters of survey respondents reporting a rise. Around four in ten say claims are denied 10% of the time, with one in ten seeing denial rates above 15%. Denials at this scale, driven by various claim denial reasons,…
For People With Opioid Addiction, Medicaid ‘Unwinding’ Raises the Stakes
CITRUS COUNTY, Fla. — It was hard enough for Stephanie to get methadone treatment when she moved to Florida from Indiana last year. The nearest clinic was almost an hour’s drive away and she couldn’t drive herself. But at least she didn’t have to worry about the cost of care. As a parent with young…
Toddler’s Backyard Snakebite Bills Totaled More Than a Quarter Million Dollars
This spring, a few days after his 2nd birthday, Brigland Pfeffer was playing with his siblings in their San Diego backyard. His mother, Lindsay Pfeffer, was a few feet away when Brigland made a noise and came running from the stone firepit, holding his right hand. She noticed a pinprick of blood between his thumb…
Impact of AI on the economy
From Bonney et al. (2024): Using a new large-scale business survey by the U.S. Census Bureau, we find that AI use is having a much greater impact on worker tasks than on employment levels at the firm level. About 27% of firms using AI report replacing worker tasks, but only about 5% experience employment change…
Engineers: Heal Thyselves (and Health Care)
By KIM BELLARD The article I can’t get out of my head is one by Greg Ip in The Wall Street Journal: Crises at Boeing and Intel Area National Emergency. I’m old enough that I remember when the Boeing 707 took airline passenger travel from the prop age to the jet age. I’m old enough…
Going In Reverse Is Faster Way Forward for Crescent Bio’s Cancer Immunotherapy
Crescent Biopharma is going public via a reverse merger with GlycoMimetics that will capitalize the combined company with $200 million. Crescent’s lead program is a bispecific antibody for cancer that replicates the properties of a Summit Therapeutics bispecific drug that recently trounced Merck’s blockbuster med Keytruda in a pivotal head-to-head study. The post Going In…
Black, Latino, Women Healthcare Leaders Sign Letters in Support of Kamala Harris
More than two dozen Black and Latino health tech leaders have endorsed Kamala Harris for president. Another group of over 500 women healthcare leaders has also come out in support of Harris. The post Black, Latino, Women Healthcare Leaders Sign Letters in Support of Kamala Harris appeared first on MedCity News.
‘You Almost Have to Be Doing It’: Why Scott Gottlieb Thinks All Doctors Will Use LLMs Soon
Large language models will soon become a much bigger part of doctors’ clinical workflows, former FDA Commissioner Scott Gottlieb said Tuesday at the 3rd Annual Summit on the Future of Rural Health Care. The post ‘You Almost Have to Be Doing It’: Why Scott Gottlieb Thinks All Doctors Will Use LLMs Soon appeared first on…
Florida Medical Device Maker Exactech Declares Bankruptcy
Exactech, a Florida device manufacturer that faces more than 2,000 state and federal lawsuits from patients who allege the company sold defective hip and knee implants, filed for bankruptcy protection Tuesday. The Gainesville-based company said in a statement it was restructuring and would be sold to an investor group of private equity and “alternative asset”…